Rona Therapeutics

Highly Engaged Employees

Rona Therapeutics is a world leading nucleic acid therapeutics company dedicated to addressing metabolic and degenerative diseases. Inceptioned in 2021, Rona Therapeutics has advanced several best-in-class siRNA therapeutics in the clinic or IND enabling stage, including PCSK9 siRNA for hypercholesteremia and APOC3 siRNA for mixed dyslipidemia. Wit... h longer duration, deep knockdown and improved tolerability, Rona Therapeutics metabolic assets have demonstrated differentiated profile to address unmet needs in cardiovascular diseases, MASH, obesity and renal diseases. Rona Therapeutics has built proprietary extrahepatic delivery platform in neuro degenerative diseases to fully exploit nucleic acid delivery potential beyond liver. With robust knockdown potency and long-term duration (Q9M or longer), multiple assets are progressing into IND enabling stage to treat complex diseases, i.e. ALS, Alzheimer's Diseases etc. that cannot be drugged with conventional modalities. The Company has raised around $70M USD from blue-chip institutional investors and strategic partners.Read More